Drug Detail:Aspruzyo sprinkle (Ranolazine [ ra-noe-la-zeen ])
Generic Name: RANOLAZINE 500mg
Dosage Form: oral granules
Drug Class: Antianginal agents
Drug Detail:Aspruzyo sprinkle (Ranolazine [ ra-noe-la-zeen ])
Generic Name: RANOLAZINE 500mg
Dosage Form: oral granules
Drug Class: Antianginal agents
Initiate ASPRUZYO Sprinkle dosing at 500 mg orally twice daily and increase to 1000 mg orally twice daily, as needed, based on clinical symptoms.
The maximum recommended daily dose of ASPRUZYO Sprinkle is 1000 mg twice daily.
If a dose of ASPRUZYO Sprinkle is missed, take the prescribed dose at the next scheduled time; do not double the next dose.
Directions for use with soft food (e.g., applesauce and yogurt)
Direction for nasogastric and gastric tube administration
Nasogastric (NG) tube: Add the content of a sachet to a plastic catheter tip syringe and add 50 mL of water. Gently shake the syringe for approximately 15 seconds. Promptly deliver through a 12 French or larger NG tube. Ensure no granules are left in the syringe. Rinse with additional water (about 15 mL) if needed.
Gastrostomy/Gastric (G) tube: Add the content of a sachet to a plastic catheter tip syringe and add 30 mL of water. Gently shake the syringe for approximately 15 seconds. Promptly deliver through a 12 French or larger G-tube. Rinse with 20 mL of water in the syringe. Ensure no granules are left in the syringe. Rinse with additional water (about 15 mL) if needed.
Dose adjustments may be needed when ASPRUZYO Sprinkle is taken in combination with other drugs [see Drug Interactions (7.1)]. Limit the maximum dose of ASPRUZYO Sprinkle to 500 mg twice daily in patients on moderate CYP3A inhibitors such as diltiazem, verapamil, and erythromycin. Use of ASPRUZYO Sprinkle with strong CYP3A inhibitors and CYP3A inducers is contraindicated [see Contraindications (4), Drug Interactions (7.1)].